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N95 respirator use during advanced pregnancy
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Abstract
Background—To determine the physiological and subjective effects of wearing an N95 filtering 
facepiece respirator (N95 FFR) in advanced stages of pregnancy.
Methods—Healthy pregnant women (n = 22) and nonpregnant women (n = 22) had 
physiological and subjective measurements taken with and without wearing an N95 FFR during 
exercise and postural sedentary activities over a 1-hour period.
Results—There were no differences between the pregnant and nonpregnant women with respect 
to heart rate, respiratory rate, oxygen saturation, transcutaneous carbon dioxide level, chest wall 
temperature, aural temperature, and subjective perceptions of exertion and thermal comfort. No 
significant effect on fetal heart rate was noted.
Conclusions—Healthy pregnant women wearing an N95 FFR for 1 hour during exercise and 
sedentary activities did not exhibit any significant differences in measured physiological and 
subjective responses compared with nonpregnant women.
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Approximately 60% of US women are employed, accounting for 46% of the national 
workforce.1,2 The number wearing a respiratory protective device (RPD), such as a 
respirator or facemask, is not precisely known, but 3.3 million industrial workers3 have the 
use of RPD as a work requirement, and 4.3 million individuals employed as nurses and 
nursing assistants (92% women)4 wear RPDs to varying degrees. With the US rate of 
pregnancy (in women age 15-44 years)5 at 103/1,000, significant numbers of pregnant 
working women may be using an RPD. Furthermore, pregnant women are at increased risk 
for morbidity and mortality from some viral respiratory infectious diseases (eg, SARS, 
pandemic influenza) that may necessitate the use of an RPD.6-9
The respiratory system undergoes pregnancy-associated changes6,10,11 that might be 
negatively impacted by an RPD. The N95 class of filtering facepiece respirator (N95 FFR) is 
*Address correspondence to National Personal Protective Technology Laboratory, 636 Cochrans Mill Rd, Pittsburgh, PA 15236. 
dtn0@cdc.gov. . 
Conflict of interest: None to report.
HHS Public Access
Author manuscript
Am J Infect Control. Author manuscript; available in PMC 2015 October 01.
Published in final edited form as:













the most commonly used RPD in both industrial and health care settings in the United 
States,3,12 but little scientific data exist on the physiological and subjective burdens imposed 
by RPDs on pregnant women,13-15 and none directly addresses N95 FFRs. The present study 
was undertaken by the US National Institute for Occupational Safety and Health to evaluate 
the physiological and subjective effects of wearing an N95 FFR during advanced pregnancy.
MATERIALS AND METHODS
Subject demographics
Twenty-two healthy, nonsmoking women in the second to mid-third trimester of pregnancy 
(ie, 13-35 weeks gestation) and 22 healthy, nonsmoking, nonpregnant women controls were 
enrolled in the study. All subjects were experienced RPD users. Mean (SD) demographic 
values of the pregnant subjects were as follows: gestation, 20.6 (4.5) weeks; age, 28.0 (2.9) 
years; height, 166.7 (5.7) cm; weight, 73.8 (18.5) kg; and body mass index (BMI), 26.8 (6.0) 
kg/m2. Mean (SD) demographic values for the controls were age 26.1 (4.0) years, height 
167.5 (5.9) cm, weight 67.5 (9.5) kg, and BMI 24.1 (3.2) kg/m2. The study was approved by 
the National Institute for Occupational Safety and Health’s Human Subjects Review Board. 
All subjects provided oral and written informed consent.
Assessment of respirator fit: N95 respirator fit testing
Subjects underwent an Occupational Safety and Health Administration respirator 
quantitative fit test16 with either a flat-fold N95 FFR or a premolded, cup-shaped N95 FFR. 
A subject who did not pass fit testing with the randomized N95 FFR was subsequently fit-
tested with the other style, and all subjects ultimately passed fit testing on 1 of the 2 
respirator models.
Subject instrumentation
Respiratory rate (RR) and chest wall skin temperature (Tchest) were monitored continuously 
with the Zephyr Bioharness (Zephyr Technology Corp, Annapolis, MD). Heart rate (HR), 
transcutaneous partial pressure of carbon dioxide (PtcCO2), and pulse-derived oxygen 
saturation (SpO2) were monitored continuously with the Tosca 500, a heated (42°C) 
combination pulse oximeter and CO2 sensor (Radiometer, Copenhagen, Denmark) attached 
to the right earlobe. Aural temperature (Taural) was obtained from the left ear with a 
WelchAllyn Pro 400 tympanic thermometer (Braun, Kronberg, Germany). Fetal heart rate 
(FHR) was measured with a Bidop ES-100V3 ultrasound fetal Doppler (Koven Technology, 
St Louis, MO).
Study protocol
Subjects were instrumented, and the order of the trials (N95 FFR) and controls (no N95 
FFR) was randomized. For trials, at baseline PtcCO2, subjects donned the N95 FFR 
(following the manufacturer’s instructions) and performed a user seal check.17 The subjects 
then performed 3 contiguous 20-minute activity phases consisting of (1) standing upright, 
(2) exercising by pedaling a Kettler RX7 reclining bicycle ergometer (Ense-Parsit, North 
Rhine-Westphalia, Germany) at 60 pedal cycles/minute and 50 W resistance, and (3) sitting 
upright in a chair. Taural was obtained at the beginning of each activity phase and every 5 
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minutes until phase completion. Subjective impressions of thermal comfort and exertion 
were obtained simultaneously using the Frank Scale of Perceived (Thermal) Comfort 
(FSPC),18 which ranges from a rating of 0 (“the coldest you have ever been”) to 10 (“the 
hottest you have ever been”), and the Borg Rating of Perceived Exertion (BRPE),19 which 
ranges from a rating of 6 (“very, very light”) to 20 (“very, very hard”).
In 17 pregnant subjects, FHR was measured at the beginning and end of each seated and 
standing session (FHR was not assessed during exercise bicycle ergometer testing owing to 
motion artifactm20 and could not be evaluated in 5 subjects during standing and sitting.) 
There was a minimum 30-minute respite between controls and trials.
Statistical analysis
Physiological and subjective data were summarized at the first (1 minute) and last (20 
minutes) time points of each activity phase for statistical analysis. Repeated-measures 
ANOVA in a mixed design (2 within-subjects factors [condition × time] and 1 between-
subjects factor [pregnancy]) was used to determine the main effect of wearing an N95 FFR 
(condition) on the study variables (except FHR) over different phases (time), along with the 
effect of pregnancy on each main effect. A Greenhouse-Geisser correction was adopted for 
assumption of sphericity, and a post-hoc pairwise comparison with Bonferroni adjustment 
was carried out for a significant F value. A P value < .05 was considered to indicate 
statistical significance. All analyses were performed using a SPSS version 18 (IBM, 
Armonk, NY).
RESULTS
Age was the sole demographic that was significantly greater for pregnant subjects (P = .03). 
Wearing an N95 FFR did not significantly affect any of the physiological or subjective 
responses in pregnant and nonpregnant subjects: HR (F = 0.582; P = .45), RR (F = 0.042; P 
= .83), SpO2 (F = 1.767; P = .19), PtcCO2 (F = 0.971; P = .33), Tchest (F = 0.006; P = .93), 
Taural (F = 1.444; P = .23), BRPE (F = 0.019; P = .89), or FSPC (F = 2.389; P = .13). 
Wearing an N95 FFR did not significantly affect FHR (F = 0.009; P = .92).
For all subjects, wearing an N95 FFR was associated with a significant effect on RR (F = 
12.548; P = .001), and FSPC (F = 34.276; P < .001). Time had a significant effect (P < .05) 
on all measured variables except PtcCO2 and Taural (Tables 1-3). N95 FFR use was 
associated with increased PtcCO2 over time during exercise (P = .04).
DISCUSSION
Our study data indicate that the physiological and subjective effects of wearing an N95 FFR 
during 1 hour of combined sedentary activities and exercise do not differ significantly 
between healthy pregnant and nonpregnant women.
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The effects of N95 FFR use on the normally higher HR of pregnancy (owing to metabolic 
demands10) was not significantly different from those in the nonpregnant subjects in the 
present series and in other investigations with similar workloads.21,22
RR
RR is relatively stable during pregnancy,10 and no significant differences were noted 
between pregnant and nonpregnant subjects. The significant (P = .001) overall decreased RR 
noted with N95 FFR use (Table 1), reflects minor RR decrements (mean, 0.94 breaths/
minute; range, 0.1-2.2 breaths/minute, median, 0.9 breaths/minute) reported previously23 
and related to a mild concomitant compensatory increase in the tidal volume.
SpO2
No significant differences in SpO2 were noted between pregnant and nonpregnant subjects 
(Table 1), and no subject had a SpO2 <97%. A previous study found that in pregnant women 
in the third trimester, SpO2 levels did not decrease over normal baseline values after 30 
minutes of wearing a gas mask with significantly greater resistance (20 cm H2O pressure) 
than an N95 FFR.15 Wearing an N95 FFR at low work levels for 1 hour results in mixed 
inhalation/exhalation N95 FFR dead space O2 levels below (16.6%) ambient levels,23,24 but 
these have not resulted in SpO2 values <95%, because the sigmoidal shape of the oxygen-
hemoglobin dissociation curve allows healthy individuals to maintain an SpO2 value of 
92%-98% breathing fractions of inspired air (FiO2) below normal ambient level (0.21).25 
Furthermore, the rightward shift of the oxygen-hemoglobin curve during pregnancy favors 
unloading of O2 in the periphery and O2 transfer across the placenta.
PtcCO2
PtcCO2 declines with pregnancy to 32-34 mm Hg owing to increased minute ventilation 
necessitated by the added metabolic demands, ventilatory stimulant effects of elevated 
progesterone, and need to develop a fetal/maternal CO2 gradient.10 No significant 
differences in PtcCO2 were found between the pregnant and nonpregnant subjects (Table 1). 
No subject was hypercapneic, and none had an increase in baseline PtcCO2 >3 mm Hg 
(Table 2). At low work levels over 1 hour, mixed inhalation/exhalation N95 FFR deadspace 
CO2 (2.8%-2.9%)23,24 exceeds ambient levels and results in rebreathing of CO2; however, 
CO2 retention is generally minimal, because respirator deadspace CO2 ≤2% is fully 
compensable in the short term.26 These findings, along with the mild increase (ie, 7.6 mm 
Hg) in PtcCO2 reported with 12 hours of N95 FFR use by female health care workers,27 
suggest that CO2 retention sufficient to cause fetal distress (PtcCO2 ≥60 mm Hg)28,29 should 
not occur in healthy pregnant women wearing an N95 FFR. The finding of a significant 
effect of N95 FFR use on PtcCO2 over time during exercise (P = .04) is related to the 
rebreathing of higher CO2 levels generated during exercise.
Chest wall and aural temperatures
The trapping of warmed, exhaled air results in an increase in N95 FFR deadspace 
temperature over ambient air temperature.30 No significant differences in Tchest and Taural 
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between pregnant and non-pregnant subjects were noted (Table 1), and the minimal 
increases observed reflect that ~10% of body heat is normally dissipated by respiration, so 
that rebreathing expelled air from the N95 FFR deadspace has minimal effect on core 
temperature.31 The significant effect of N95 FFR use on Tchest (P < .001) may indicate a 
greater effect of rebreathed warm air on the peripheral temperature of skin closest to the 
pulmonary system (ie, chest wall).32
FHR
Use of an N95 FFR was not associated with any significant effects on FHR during any of the 
activity phases. No fetal bradycardia or tachycardia was noted (Table 3), reflecting the lack 
of significant impact on the measured maternal physiological variables.
BRPE
All subjects similarly rated the sedentary portions of the study (ie, standing and sitting) as 
compatible with “very, very light” and the exercise portion as consistent with “very light” in 
terms of exertion19 (Table 2). Wearing an N95 FFR was perceived as not significantly 
different between groups as relates to energy expenditure, similar to previous reports,23,24,33 
likely related to the decreased filter resistance of modern N95 FFRs33,34 on breathing 
resistance.
FSPC
All subjects indicated thermal ratings ranging from “neither hot nor cold” to “slightly hot”18 
(Table 3). The greater heat perception among all subjects when wearing an N95 FFR (P ≤ .
001) is likely related to the respirator’s barrier effects on facial skin heat loss mechanisms 
(evaporation, convection) and increased N95 FFR dead space temperature.31
Limitations of this study include the relatively small number of pregnant subjects studied (n 
= 22), reflecting the difficulty recruiting experienced RPD users from this special 
population. In addition, because only 3 of our 22 pregnant subjects (13%) had a BMI >30, 
we cannot comment on the effects of N95 FFR use by obese pregnant women. Although few 
pregnant subjects were in their third trimester, no significant differences in pulmonary 
function tests between the second and third trimesters have been reported.35 Only 2 N95 
FFR styles (cup-shaped and flat fold) were tested, so that we cannot comment on other 
styles (eg, duckbill, pleated). Only healthy pregnant women were recruited for the study, so 
that the impact of N95 FFR use by pregnant women with significant cardiopulmonary 
disorders is unknown, although in patients with various mild airway diseases (eg, COPD, 
asthma, chronic rhinitis), N95 FFRs were found to have less physiological impact than other 
negative-pressure RPDs.36
The use of an N95 FFR by healthy, pregnant women in advanced stages of pregnancy did 
not result in significant differences in physiological and subjective findings compared with 
healthy, nonpregnant women during sedentary activities and exercise over 1 hour. These 
findings, and recent evidence of physiological tolerance to long-term (12 hours) use of an 
N95 FFR by nonpregnant women,27 suggest that N95 FFRs are likely to be safe for use by 
healthy, pregnant women and should serve as a stimulus for a larger study. Research 
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reporting that the use of medical/surgical masks results in similar physiological effects as 
N95 FFR37 implies that these protective facemasks are also safe for use during pregnancy. 
Pregnant women with concerns about the use of N95 FFRs should consult a licensed 
medical provider with knowledge of the topic.
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Table 1
Physiological variables for pregnant and nonpregnant subjects wearing an N95 FFR
Trial
Nonpregnant subjects (n = 22) Pregnant subjects (n = 22)
Study variable* No respirator N95 FFR No respirator N95 FFR
Standing
 HR
  1 min 71.0 (13.4) 74.9 (14.2) 89.3 (13.8) 95.5 (13.0)
  20 min 76.9 (14.8) 78.6 (22.2) 96.3 (16.7) 100.1 (14.1)
 RR
  1 min 17.8 (3.5) 16.6 (3.8) 18.0 (2.34) 17.9 (3.3)
  20 min 17.3 (3.6) 17.2 (3.14) 17.6 (2.9) 16.3 (1.6)
 SpO2
  1 min 98.9 (0.9) 99.1 (0.5) 99.2 (0.7) 99.0 (0.5)
  20 min 98.7 (1.6) 99.1 (0.6) 99.1 (0.6) 99.0 (0.5)
 PtcCO2
  1 min 36.7 (3.5) 37.5 (3.5) 32.1 (1.8) 32.6 (2.4)
  20 min 37.4 (4.6) 35.1 (8.4) 32.2 (2.2) 32.2 (1.5)
 Tchest
  1 min 34.9 (1.4) 34.2 (1.9) 35.7 (0.7) 34.8 (1.4)
  20 min 34.8 (1.3) 34.8 (1.3) 35.6 (0.8) 35.4 (1.0)
 Taural
  1 min 36.6 (0.4) 36.7 (0.4) 36.8 (0.3) 36.8 (0.3)
  20 min 36.6 (0.4) 36.4 (0.4) 36.7 (0.4) 36.7 (0.3)
Exercise
 HR
  1 min 87.9 (18.9) 89.3 (18.3) 106.2 (11.8) 106.5 (13.8)
  20 min 98.8 (18.2) 105.5 (15.9) 120.3 (17.1) 118.9 (14.6)
 RR
  1 min 21.9 (3.3) 19.7 (3.9) 21.5 (4.3) 20.6 (3.7)
  20 min 26.4 (4.2) 24.9 (6.1) 26.9 (4.2) 24.9 (4.7)
 SpO2
  1 min 98.7 (1.1) 98.6 (1.0) 98.7 (1.3) 98.9 (0.7)
  20 min 98.7 (1.2) 98.8 (0.7) 98.9 (0.7) 98.7 (1.3)
PtcCO2
  1 min 36.7 (6.0) 37.6 (2.9) 32.3 (2.2) 32.9 (2.36)
  20 min 37.4 (3.3) 38.7 (3.1) 31.3 (3.0) 33.3 (2.2)
 Tchest
  1 min 34.9 (1.2) 34.8 (1.3) 35.6 (0.9) 35.4 (0.9)
  20 min 35.4 (1.1) 35.4 (0.9) 35.9 (0.8) 36.1 (0.8)
 Taural
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Trial
Nonpregnant subjects (n = 22) Pregnant subjects (n = 22)
Study variable* No respirator N95 FFR No respirator N95 FFR
  1 min 36.6 (0.4) 36.4 (0.4) 36.7 (0.4) 36.6 (0.3)
  20 min 36.7 (0.4) 36.5 (0.4) 36.8 (0.4) 36.7 (0.3)
Sitting
 HR
  1 min 81.2 (16.4) 82.7 (18.3) 99.0 (15.2) 98.8 (15.0)
  20 min 70.6 (12.8) 73.7 (14.8) 91.3 (12.5) 90.6 (11.0)
 RR
  1 min 20.2 (3.7) 19.3 (4.7) 19.1 (4.1) 19.9 (4.12)
  20 min 17.8 (3.8) 17.3 (3.2) 17.9 (3.3) 16.9 (3.7)
 SpO2
  1 min 98.8 (1.7) 98.8 (1.1) 99.1 (1.0) 99.1 (0.7)
  20 min 99.0 (0.7) 99.2 (0.7) 99.2 (0.6) 99.2 (0.6)
 PtcCO2
  1 min 37.1 (3.2) 37.3 (4.5) 31.3 (2.4) 32.3 (2.8)
  20 min 36.9 (3.0) 36.8 (3.1) 31.9 (2.6) 32.4 (2.5)
 Tchest
  1 min 35.6 (1.0) 35.6 (1.1) 35.9 (0.9) 36.0 (0.7)
  20 min 35.6 (1.1) 35.5 (1.1) 36.1 (0.9) 36.0 (0.8)
 Taural
  1 min 36.7 (0.4) 36.5 (0.4) 36.8 (0.3) 36.7 (0.3)
  20 min 36.7 (0.4) 36.4 (0.5) 36.8 (0.3) 36.6 (0.3)
Data are mean (SD).
*
None of the results comparing study variables between pregnant and nonpregnant subjects are statistically significant (P > .05).
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Table 2
Subjective variables for pregnant and nonpregnant subjects wearing an N95 FFR
Trial
Nonpregnant subjects (n = 22) Pregnant subjects (n = 22)
Study variable No respirator N95 FFR No respirator N95 FFR
Standing
 BRPE
  1 min 6.5 (1.1) 6.0 (1.5) 6.7 (1.4) 6.4 (0.7)
  20 min 6.7 (1.2) 6.9 (1.5) 6.9 (1.4) 7.3 (1.8)
 FSPC
  1 min 4.6 (0.8) 4.6 (1.0) 4.5 (0.7) 4.9 (0.4)
  20 min 4.4 (0.6) 4.9 (0.8) 4.6 (0.7) 5.4 (1.0)
Exercise
 BRPE
  1 min 8.1 (1.8) 8.4 (2.1) 8.4 (1.9) 9.0 (2.0)
  20 min 9.7 (2.6) 10.8 (2.2) 10.6 (2.5) 11.5 (3.1)
 FSPC
  1 min 4.8 (1.0) 5.1 (0.7) 4.6 (0.5) 5.1 (0.7)
  20 min 5.7 (1.0) 6.1 (1.0) 5.5 (1.0) 6.3 (1.0)
Sitting
 BRPE
  1 min 7.0 (1.6) 7.4 (1.6) 7.0 (1.6) 7.8 (2.1)
  20 min 6.4 (1.1) 6.3 (0.5) 6.4 (1.1) 6.5 (0.6)
 FSPC
  1 min 5.5 (1.1) 5.8 (1.0) 5.0 (0.5) 5.7 (0.9)
  20 min 4.5 (0.7) 5.0 (0.9) 4.7 (0.5) 5.0 (0.7)
Data are mean (SD).
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Table 3
FHR responses to sedentary activity and exercise in pregnant women (n = 17)
Trial
Study variable No respirator Respirator
Standing
 1 min 140.6 (10.7) 143.4 (8.9)
 20 min 145.9 (10.6) 144.5 (10.0)
Exercise
 1 min 145.6 (7.6) 141.7 (8.5)
 20 min 148.8 (11.6) 149.1 (9.5)
Sitting
 1 min 144.5 (10.7) 143.6 (12.6)
 20 min 148.1 (10.5) 150.0 (12.8)
Data are mean (SD).
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